Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by Shanoj et al.
Kristin M D'SilvaNaomi Serling-BoydTiffany Y-T HsuJeffrey A SparksZachary Scott WallacePublished in: Annals of the rheumatic diseases (2021)